Exozymes's three largest insider shareholders as of September 09, 2026 are Capital Holdings, Llc Mdb (TenPercentOwner, 3.93Mn shares), Tyler Paz Korman (Chief Scientific Officer, 762.84K shares), Tyler Paz Korman (Chief Scientific Officer, 762.84K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Capital Holdings, Llc Mdb | TenPercentOwner | 3,931,133 | 0 | 3,931,133 | 57.6% | 18 Nov, 2024 |
| 2 | Tyler Paz Korman | Chief Scientific Officer | 1,491,960 | 0 | 1,491,960 | 21.9% | 24 Aug, 2026 |
| 3 | Paul Hideo Opgenorth | Vice President, Development | 1,286,299 | 0 | 1,286,299 | 18.8% | 07 Apr, 2026 |
| 4 | Damien Alan Perriman | Chief Commercial Officer | 91,258 | 0 | 91,258 | 1.3% | 24 Aug, 2026 |
| 5 | Michael Heltzen | Chief Executive Officer | 13,853 | 0 | 13,853 | 0.2% | 02 Sep, 2026 |
| 6 | Fouad Nawaz | Vice President Finance | 12,977 | 0 | 12,977 | 0.2% | 07 Apr, 2026 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 19 Aug, 2026 | Damien Alan Perriman | Chief Commercial Officer | Acquired M | 19,612 | — | — | 28,499 | Direct |
| 19 Aug, 2026 | Tyler Paz Korman | Chief Scientific Officer | Acquired M | 32,964 | — | — | 762,837 | Direct |
| 19 Aug, 2026 | Damien Alan Perriman | Chief Commercial Officer | Disposed M | 19,612 | $0.00 | $0 | 43,147 | Direct |
| 19 Aug, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed M | 32,964 | $0.00 | $0 | 46,140 | Direct |
| 08 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.04 | $7.53K | 729,873 | Direct |
| 08 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.04 | $7.53K | 729,873 | Direct |
| 08 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.04 | $7.53K | 729,873 | Direct |
| 08 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.04 | $7.53K | 729,873 | Direct |
| 09 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.53 | $7.89K | 729,123 | Direct |
| 09 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.53 | $7.89K | 729,123 | Direct |
| 09 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.53 | $7.89K | 729,123 | Direct |
| 09 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Disposed S | 750 | $10.53 | $7.89K | 729,123 | Direct |
| 01 Apr, 2026 | Damien Alan Perriman | Chief Commercial Officer | Acquired A | 62,759 | $0.00 | $0 | 62,759 | Direct |
| 01 Apr, 2026 | Damien Alan Perriman | Chief Commercial Officer | Acquired A | 146,437 | $0.00 | $0 | 146,437 | Direct |
| 01 Apr, 2026 | Damien Alan Perriman | Chief Commercial Officer | Acquired A | 8,887 | $8.44 | $75.01K | 0 | Direct |
| 01 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Acquired A | 5,332 | $8.44 | $45.00K | 730,623 | Direct |
| 01 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Acquired A | 5,332 | $8.44 | $45.00K | 730,623 | Direct |
| 01 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Acquired A | 5,332 | $8.44 | $45.00K | 730,623 | Direct |
| 01 Apr, 2026 | Tyler Paz Korman | Chief Scientific Officer | Acquired A | 5,332 | $8.44 | $45.00K | 730,623 | Direct |
| 01 Apr, 2026 | Paul Hideo Opgenorth | Vice President, Development | Acquired A | 3,999 | $8.44 | $33.75K | 645,149 | Direct |